The neurobiology of pleasure, reward processes, addiction and their health implications

Neuroendocrinology Letters

Volumn 25, Issue 4, 2004, Pages 235-251

  Esch, Tobias ^a,c   Stefano, George B ^b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c Beijing Foreign Affairs School   (China)

Author keywords

Addiction; Dopamine; Endorphins; Health; Motivation; Placebo; Pleasure; Reward

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL; AMPHETAMINE; CAFFEINE; CENTRAL STIMULANT AGENT; COCAINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIAMORPHINE; DOPAMINE; ENDORPHIN; GLUTAMIC ACID; MORPHINE; NICOTINE; OPIATE; OPIATE PEPTIDE; SEROTONIN;

BEHAVIOR DISORDER; BRAIN FUNCTION; BRAIN REGION; COGNITION; COPING BEHAVIOR; DOPAMINERGIC ACTIVITY; DRUG DEPENDENCE; EATING; HAPPINESS; HEALING; HEALTH STATUS; HUMAN; LIMBIC SYSTEM; MOTIVATION; MUSIC THERAPY; NEUROBIOLOGY; PRODUCTIVITY; PROTEIN FUNCTION; REPRODUCTION; REVIEW; REWARD; SATISFACTION; SENSORY STIMULATION; SEXUAL BEHAVIOR; SOCIAL INTERACTION; SURVIVAL; TRUST; WELLBEING;

EID: 6444219646     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Esch T. [Health in stress: Change in the stress concept and its significance for prevention, health and life style]. Gesundheitswesen 2002; 64:73-81.
2. Esch T. [Stress, adaptation, and self-organization: balancing processes facilitate health and survival]. Forsch Komplementarmed Klass Naturheilkd 2003; 10:330-41.
3. Smith DF. Functional salutogenic mechanisms of the brain. Perspect Biol Med 2002; 45:319-28.
4. Bozarth MA. Pleasure systems in the brain. In: Wartburton DM, editors. Pleasure: The politics and the reality. New York: Wiley & Sons; 1994.
5. Longman Dictionary of Contemporary English. Second ed. Berlin: Langenscheidt; 1987.
6. Nestler EJ, Malenka RC. The addicted brain. Sci Am 2004; 290: 78-85.
7. Troland LT. The fundamentals of human motivation. New York: Van Nostrand Reinhold; 1928.
8. Stefano GB, Fricchione GL, Slingsby BT, Benson H. The placebo effect and relaxation response: Neural processes and their coupling to constitutive nitric oxide. Brain Research: Brain Research Reviews 2001; 35:1-19.
9. Hui KKS, Liu J, Makris N, Gollub RL, Chen AJW, Moore CI et al. Acupuncture modulates the limbic system and subcortical gray structures of the human brain: Evidence from fMRI studies in normal subjects. Human Brain Mapping 2000; 9:13-25.
10. Esch T, Stefano GB, Fricchione GL, Benson H. The role of stress in neurodegenerative diseases and mental disorders. Neuroendocrinology Letters 2002; 23:199-208.
11. Davidson RJ, Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 1999; 3:11-21.
12. Esch T. [Music medicine: Music in association with harm and healing]. Musikphysiol Musikermed 2003; 10:213-24.
13. Campbell A. The limbic system and emotion in relation to acupuncture. Acupuncture in Medicine 1999; 17:124-8.
14. Esch T, Guarna M, Bianchi E, Zhu W, Stefano GB. Commonalities in the central nervous system's involvement with complementary medical therapies: Limbic morphinergic processes. Medical Science Monitor 2004; 10:MS6-MS17.
15. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001; 2:119-28.
16. Nestler EJ, Malenka RC, Hyman SE. Molecular basis of neuropharmacology. Columbus: McGraw-Hill; 2001.
17. Small DM, Zatorre RJ, Dagher A, Evans AC, Jones-Gotman M. Changes in brain activity related to eating chocolate: From pleasure to aversion. Brain 2001; 124:1720-33.
18. Olds J. Drives and reinforcements: Behavioral studies of hypothalamic functions. New York: Raven Press; 1977.
19. Wise RA. Catecholamine theories of reward: A critical review. Brain Res 1978; 152:215-47.
20. Bozarth MA. Ventral tegmental reward system. In: Oreland L, Engel J, editors. Brain reward systems and abuse. New York: Raven Press; 1987.
21. Rodriguez dF, Navarro M. Role of the limbic system in dependence on drugs. Ann Med 1998; 30:397-405.
22. Weiss F, Koob GF. Drug addiction: Functional neurotoxicity of the brain reward systems. Neurotox Res 2001; 3:145-56.
23. Berridge KC. Pleasures of the brain. Brain Cogn 2003; 52 106-28.
24. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159:1642-52.
25. Mitchell JB, Stewart J. Facilitation of sexual behaviors in the male rat associated with intra-VTA injections of opiates. Pharmacol Biochem Behav 1990; 35:643-50.
26. Esch T, Fricchione GL, Stefano GB. The therapeutic use of the relaxation response in stress-related diseases. Medical Science Monitor 2003; 9:RA23-RA34.
27. Stefano GB, Esch T, Cadet P, Zhu W, Mantione K, Benson H. Endocannabinoids as autoregulatory signaling molecules: coupling to nitric oxide and a possible association with the relaxation response. Med Sci Monit 2003; 9:RA63-RA75.
28. Aung AT, Hickman NJ, III, Moolchan ET. Health and performance related reasons for wanting to quit: Gender differences among teen smokers. Subst Use Misuse 2003; 38:1095-107.
29. Botvin GJ, Griffin KW, Diaz T, Miller N, Ifill-Williams M. Smoking initiation and escalation in early adolescent girls: One-year follow-up of a school-based prevention intervention for minority youth. J Am Med Womens Assoc 1999; 54:139-43, 152.
30. Cachelin FM, Weiss JW, Garbanati JA. Dieting and its relationship to smoking, acculturation, and family environment in Asian and Hispanic adolescents. Eating Disorders: The Journal of Treatment and Prevention 2003; 11:51-61.
31. Dzien A, Dzien-Bischinger C, Hoppichler F, Lechleitner M. The metabolic syndrome as a link between smoking and cardiovascular disease. Diabetes Obes Metab 2004; 6:127-32.
32. Epstein JA, Botvin GJ, Spoth R. Predicting smoking among rural adolescents: Social and cognitive processes. Nicotine Tob Res 2003; 5:485-91.
33. Gilman SE, Abrams DB, Buka SL. Socioeconomic status over the life course and stages of cigarette use: Initiation, regular use, arid cessation. J Epidemiol Community Health 2003; 57:802-8.
34. Jefferis B, Graham H, Manor O, Power C. Cigarette consumption and socio-economic circumstances in adolescence as predictors of adult smoking. Addiction 2003; 98:1765-72.
35. Stangl V, Baumann G, Stangl K. Coronary atherogenic risk factors in women. Eur Heart J 2002; 23:1738-52.
36. Yorulmaz F, Akturk Z, Dagdeviren N, Dalkilic A. Smoking among adolescents: Relation to school success, socioeconomic status nutrition and self-esteem. Swiss Med Wkly 2002; 132:449-54.
37. Bozarth MA. Drug addiction as a psychobiological process. In: Wartburton DM, editors. Addiction Controversies. London: Harwood Academic Publishers; 1990.
38. Bozarth MA. New perspectives on cocaine addiction: Recent findings from animal research. Can J Physiol Pharmacol 1989; 67 1158-67.
39. Esch T, Stefano GB, Fricchione GL, Benson H. Stress-related diseases: A potential role for nitric oxide. Medical Science Monitor 2002; 8:RA103-RA118.
40. Esch T, Stefano GB. Proinflammation: A common denominator or initiator of different pathophysiological disease processes. Medical Science Monitor 2002; 8:1-9.
41. Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag; 1987.
42. Bozarth MA. The mesolimbic dopamine system as a model. reward system. In: Willner P, Scheel-Krüger J, editors. The Mesolimbic Dopamine System: From Motivation to Action. London: Wiley & Sons; 1991.
43. Rossetti ZL, Hmaidan Y, Gessa GL. Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 1992; 221 227-34.
44. Wise RA, Bozarth MA. Brain reward circuitry: Four circuit elements «wired» in apparent series. Brain Res Bull 1984; 12: 203-8.
45. Renaud SC, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr 1992; 55:1012-7.
46. Takkouche B, Regueira-Mendez C, Garcia-Closas R, Figueiras A, Gestal-Otero JJ, Hernan MA. Intake of wine, beer, and spirits and the risk of clinical common cold. Am J Epidemiol 2002; 155:853-8.
47. Truelsen T, Thudium D, Gronbaek M. Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 2002; 59:1313-9.
48. Hoidrup S, Gronbaek M, Gottschau A, Lauritzen JB, Schroll M. Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 1999; 149:993-1001.
49. Hamilton ME, Bozarth MA. Feeding elicited by dynorphin (1-13) microinjections into the ventral tegmental area in rats. Life Sci 1988; 43:941-6.
50. Heath RG. Pleasure response of human subjects to direct stimulation of the brain. In: Heath RG, editors. The Role of Pleasure in Human Behavior. New York: Hoeber; 1964.
51. Esch T, Stefano GB, Fricchione GL, Benson H. Stress in cardiovascular diseases. Medical Science Monitor 2002; 8: A93-RA101.
52. Robinson TE, Berridge KC. Incentive-sensitization and addiction. Addiction 2001; 96:103-14.
53. Fuente-Fernandez R, Schulzer M, Stoessl AJ. The placebo effect in neurological disorders. Lancet Neurol 2002; 1:85-91.
54. McClung CA, Nestler EJ. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci 2003; 6: 1208-15.
55. Zhang L, Lou D, Jiao H, Zhang D, Wang X, Xia Y et al. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 2004; 24:3344-54.
56. Murphy CA, Russig H, Pezze MA, Ferger B, Feldon J. Amphetamine withdrawal modulates FosB expression in mesolimbic dopaminergic target nuclei: effects of different schedules of administration. Neuropharmacology 2003; 44:926-39.
57. Stefano GB, Goumon Y, Casares F, Cadet P, Fricchione GL, Rialas C et al. Endogenous morphine. Trends in Neurosciences 2000; 9: 436-42.
58. Kornetsky C. Brain-stimulation reward, morphine-induced oral stereotypy, and sensitization: implications for abuse. Neurosci Biobehav Rev 2004; 27:777-86.
59. Thompson AC, Kristal MB. Opioids in the ventral tegmental area facilitate the onset of maternal behavior in the rat. Society for Neuroscience Abstracts 1994; 18:659.
60. Gil-Verona JA, Pastor JF, de Paz F, Barbosa M, Macias-Fernandez JA, Maniega MA et al. [Neurobiology of addiction to drugs of abuse]. Rev Neurol 2003; 36:361-5.
61. Esch T. [The significance of stress for the cardiovascular system: Stress-associated cardiovascular diseases and non-pharmaceutical therapy options]. Apothekenmagazin 2003; 21:8-15.
62. Fibiger HC, Phillips AG. Dopamine and the neural mechanisms of reinforcement. In: Horn AS, Westerink BHC, Korf J, editors. The Neurobiology of Dopamine. New York: Academic Press; 1979.p. 597-615.
63. Esch T, Gesenhues S. [Terminology, classification and rational diagnostics in depression]. Psycho 2002; 28:S21-S27.
64. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987; 94:469-92.
65. Vetulani J. Drug addiction. Part II. Neurobiology of addiction. Pol J Pharmacol 2001; 53:303-17.
66. Sher L. The placebo effect on mood and behavior: possible role of opioid and dopamine modulation of the hypothalamic-pituitary-adrenal system. Forsch Komplementarmed Klass Naturheilkd 2003; 10:61-8.
67. Fuente-Fernandez R, Stoessl AJ. The placebo effect in Parkinson's disease. Trends Neurosci 2002; 25:302-6.
68. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, Mc-Ginnis S et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002; 159:728-37.
69. Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 2003; 19:1709-15.
70. Stefano GB, Fricchione GL. The biology of deception: The evolution of cognitive coping as a denial-like process. Med Hypotheses 1995; 44:311-4.
71. Travis F, Tecce JJ, Guttman J. Cortical plasticity, contingent negative variation, and transcendent experiences during practice of the Transcendental Meditation technique. Biol Psychol 2000; 55:41-55.
72. Salamon E, Kim M, Beaulieu J, Stefano GB. Sound therapy induced relaxation: down regulating stress processes and pathologies. Med Sci Monit 2003; 9:RA96-RA101.
73. Kobasa SC, Maddi SR, Kahn S. Hardiness and health: a prospective study. J Pers Soc Psychol 1982; 42:168-77.
74. Lynch JJ. The Broken Heart: The medical consequences of loneliness. In: New York: Basic Books; 1977.
75. Orth-Gomer K, Unden AL, Edwards ME. Social isolation and mortality in ischemic heart disease. A 10-year follow-up study of 150 middle-aged men. Acta Med Scand 1988; 224:205-15.
76. Kobasa SC, Maddi SR, Puccetti MC, Zola MA. Effectiveness of hardiness, exercise and social support as resources against illness. J Psychosom Res 1985; 29:525-33.
77. Wolff AC, Ratner PA. Stress, social support, and sense of coherence. West J Nurs Res 1999; 21:182-97.
78. Kobasa SC, Spinetta JJ, Cohen J, Crano WD, Hatchett S, Kaplan BH et al. Social environment and social support. Cancer 1991; 67: 88-93.
79. Antonovsky A. Implications of socio-economic differentials in mortality for the health system. Popul Bull 1980; 42-52.
80. Langius A, Bjorvell H, Antonovsky A. The sense of coherence concept and its relation to personality traits in Swedish samples. Scand J Caring Sci 1992; 6:165-71.
81. Seligman ME, Csikszentmihalyi M. Positive psychology. An introduction. Am Psychol 2000; 55:5-14.
82. Bandura A. Social Foundations of Thought and Action. Englewood Cliffs: Prentice-Hall; 1986.
83. Seligman ME. Helplessness: On depression, development, and death. New York: Freeman; 1992.
84. Myers DG. The funds, friends, and faith of happy people. Am Psychol 2000; 55:56-67.
85. Csikszentmihalyi M. If we are so rich, why aren't we happy? Am Psychol 1999; 54:821-7.
86. Esch T. Musical heating in mental disorders. In: Stefano GB, Bernstein SR, Kim M, editors. Musical heating. Warsaw: Medical Science International; 2003.
87. Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol 2000; 55:68-78.
88. Taylor SE, Kemeny ME, Reed GM, Bower JE, Gruenewald TL. Psychological resources, positive illusions, and health. Am Psychol 2000; 55:99-109.
89. Siegrist J. [Non-reciprocal social exchange is a health risk: a medical sociological research model]. Forsch Komplementarmed Klass Naturheilkd 2002; 9:31-6.
90. Lazar S, Bush G, Gollub R, Fricchione GL, Khatsa G, Benson H. Functional brain mapping of the relaxation response and meditation. Neuroreport 2000; 11:1585.
91. Newberg A, Alavi A, Baime M, Pourdehnad M, Santanna J, d'Aquili E. The measurement of regional cerebral blood flow during the complex cognitive task of meditation: a preliminary SPECT study. Psychiatry Res 2001; 106:113-22.
92. Elias AN, Wilson AF. Serum hormonal concentrations following transcendental meditation-potential role of gamma aminobutyric acid. Med Hypotheses 1995; 44:287-91.
93. Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med 2003; 65: 564-70.
94. Davidson RJ. Affective style, psychopathology, and resilience: Brain mechanisms and plasticity. Am Psychol 2000; 55: 196-214.
95. Altenmuller EO. How many music centers are in the brain? Ann N Y Acad Sci 2001; 930:273-80.
96. Altenmuller EO. [Apollo in us: How the brain processes music]. Musikphysiol Musikermed 2002; 9:24.
97. Salamon E, Bernstein SR, Kim SA, Kim M, Stefano GB. The effects of auditory perception and musical preference on anxiety in naive human subjects. Med Sci Monit 2003; 9:CR396-CR399.
98. Stefano GB, Zhu W, Cadet P, Salamon E, Mantione KJ. Music alters constitutively expressed opiate and cytokine processes in listeners. Medical Science Monitor 2004; 10:MS18-MS27.
99. Bianchi E, Alessandrini C, Guarna M, Tagliamonte A. Endogenous codeine and morphine are stored in specific brain neurons. Brain Res 1993; 627:210-5.
100. Spector S, Munjal I, Schmidt DE. Endogenous morphine and codeine. Possible role as endogenous anticonvulsants. Brain Res 2001; 915:155-60.
101. de la Torre JC, Pappas BA, Prevot V, Emmerling MR, Mantione K, Fortin T et al. Hippocampal nitric oxide upregutation precedes memory loss and A beta I-40 accumulation after chronic brain hypoperfusion in rats. Neurological Research 2003; 25:635-41.
102. Spencer H. Principles of Psychology. New York: Appleton; 1880.
103. Stefano GB, Scharrer B. Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol 1994; 4: 7-68.
104. Zhu W, Ma Y, Cadet P, Yu D, Bilfinger TV, Bianchi E et al. Presence of reticuline in rat brain: A pathway for morphine biosynthesis. Mol Brain Res 2003; 117:83-90.
105. Heaton JP, Adams MA. Update on central function relevant to sex: remodeling the basis of drug treatments for sex and the brain. Int J Impot Res 2003; 15 Suppl 5:S25-S32.
106. Routtenberg A, Lindy J. Effects of the availability of rewarding septal and hypothalamic stimulation on bar pressing for food under conditions of deprivation. J Comp Physiol Psychol 1965; 60: 58-61.
107. Spintge R. Some neuroendocrinological effects of socalled anxiolytic music. Int J Neurol 1985; 19-20:186-96.
108. Ma SX. Enhanced nitric oxide concentrations and expression of nitric oxide synthase in acupuncture points/meridians. J Altern Complement Med 2003; 9:207-15.
109. Kaptchuk TJ. Acupuncture: theory, efficacy, and practice. Ann Intern Med 2002; 136:374-83.
110. Jang MH, Shin MC, Kim YP, Kim EH, Kim CJ. Effect of acupuncture on nitric oxide synthase expression in cerebral cortex of streptozotocin-induced diabetic rats. Acupunct Electrother Res 2003; 28:1-10.
111. Yang R, Huang ZN, Cheng JS. Anticonvulsion effect of acupuncture might be related to the decrease of neuronal and inducible nitric oxide synthases. Acupunct Electrother Res 2000; 25: 137-43.
112. Meissner W, Weiss T, Trippe RH, Hecht H, Krapp C, Miltner WH. Acupuncture decreases somatosensory evoked potential amplitudes to noxious stimuli in anesthetized volunteers. Anesth Analg 2004; 98: 41-7, table.
113. Lund I, Yu LC, Uvnas-Moberg K, Wang J, Yu C, Kurosawa M et al. Repeated massage-Like stimulation induces long-term effects on nociception: contribution of oxytocinergic mechanisms. Eur J Neurosci 2002; 16:330-8.
114. Piotrowski MM, Paterson C, Mitchinson A, Kim HM, Kirsh M, Hinshaw DB. Massage as adjuvant therapy in the management of acute postoperative pain: a preliminary study in men. J Am Coll Surg 2003; 197:1037-46.
115. Woods DL, Dimond M. The effect of therapeutic touch on agitated behavior and cortisol in persons with Alzheimer's disease. Biol Res Nurs 2002; 4:104-14.
116. Wikstrom S, Gunnarsson T, Nordin C. Tactile stimulus and neurohormonal response: a pilot study. Int J Neurosci 2003; 113: 787-93.
117. Benson H. Beyond the relaxation response. New York: Times Books; 1984.
118. de la Torre JC, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: The role of constitutive nitric oxide. Brain Res Rev 2000; 34:119-36.
119. Steelman VM. Intraoperative music therapy. Effects on anxiety, blood pressure. AORN J 1990; 52:1026-34.
120. Knight WE, Rickard PhD NS. Relaxing music prevents stress-induced increases in subjective anxiety, systolic blood pressure, and heart rate in healthy males and females. J Music Ther 2001; 38: 54-72.
121. Fricchione GL, Mendoza A, Stefano GB. Morphine and its psychiatric implications. Adv Neuroimmunol 1994; 4:117-32.
122. Moyer CA, Rounds J, Hannum JW. A meta-analysis of massage therapy research. Psychol Bull 2004; 130:3-18.
123. Diego MA, Field T, Sanders C, Hernandez-Reif M. Massage therapy of moderate and light pressure and vibrator effects on EEG and heart rate. Int J Neurosci 2004; 114:31-44.
124. Walach H, Guthlin C, Konig M. Efficacy of massage therapy in chronic pain: a pragmatic randomized trial. J Altern Complement Med 2003; 9:837-46.
125. Cardinale GJ, Donnerer J, Finck AD, Kantrowitz JD, Oka K, Spector S. Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sci 1987; 40:301-6.
126. Donnerer J, Oka K, Brossi A, Rice KC, Spector S. Presence and formation of codeine and morphine in the rat. Proc Natl Acad Sci USA 1986; 83:4566-7.
127. Donnerer J, Cardinale G, Coffey J, Lisek CA, Jardine I, Spector S. Chemical characterization and regulation of endogenous morphine and codeine in the rat. J Pharmacol Exp Ther 1987; 242: 83-7.
128. Gintzler AR, Levy A, Spector S. Antibodies as a means of isolating and characterizing biologically active substances: Presence of a non-peptide morphine-like compound in the central nervous system. Proc Natl Acad Sci USA 1976; 73:2132-6.
129. Kodaira H, Spector S. Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes. Proceedings of the National Academy of Sciences of the United States of America 1988; 85:1267-71.
130. Kodaira H, Listek CA, Jardine I, Arimura A, Spector S. Identification of the convusant opiate thebaine in the mammalian brain. Proc Natl Acad Sci, USA 1989; 86:716-9.
131. Bianchi E, Alessandrini C, Guarna M, Tagliamonte A. Endogenous codeine and morphine are stored in specific brain neurons. Brain Research 1993; 627:210-5.
132. Bianchi E, Guarna M, Tagliamonte A. Immunocytochemical localization of endogenous codeine and morphine. Adv Neuroimmunol 1994; 4:83-92.
133. Guarna M, Neri C, Petrioli F, Bianchi E. Potassium-induced release of endogenous morphine form rat brain slices. J Neurochem 1998; 70:147-52.
134. Cadet P, Mantione KJ, Stefano GB. Molecular identification and functional expression of mu3, a novel alternatively spliced variant of the human mu opiate receptor gene. Journal of Immunology 2003; 170: 118-23.
135. Stefano GB, Fricchione GL. The biology of deception: Emotion and morphine. Med Hypotheses 1995; 49:51-4.
136. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004; 303:1162-7.
137. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978; 2:654-7.
138. Guarna M, Neri C, Bartolini A, Ghelardini C, Galeotti N, Noli L et al. Effects of endogenous morphine deprivation on memory retention of passive avoidance learning in mice. Neuropsychopharmacology 2004; In press.
139. MacDonald AW, III, Cohen JD, Stenger VA, Carter CS. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 2000; 288:1835-8.
140. Stefano GB, Salzet B, Fricchione GL. Enkelytin and opioid peptide association in invertebrates and vertebrates: immune activation and pain. Immunol Today 1998; 19:265-8.